Study of the Pharmacodynamics, Pharmacokinetics, Safety, and Immunogenicity of Single Escalating Doses of BCD-180 in Healthy Volunteers
Clinical trial NCT05407779 · COMPLETED
Trial details
- NCT number
- NCT05407779
- Sponsor
- Biocad
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-22
- Primary completion
- 2023-09-30
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.